Professor of Hematology and Oncology, Emory University
Hematology
Dr. Edmund K. Waller, MD
|
|
Give Review
Doctor Edmund K. Waller, MD is an expert in the field of Hematology. He went to medical school at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18/49 in Research/PrimaryCare. He over the years received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Edmund Waller is a published MD. He has 101 papers published. The most current publication "Circulating Progenitor Cells is Linked to Cognitive Decline in Healthy Adults." Doctor Edmund K. Waller, MD accepts all Medicare patients.
Publications
- Circulating Progenitor Cells is Linked to Cognitive Decline in Healthy Adults.
- New Cancers after autotransplantations for multiple myeloma.
- Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges.
- Low blood lymphocyte count at 30 days post transplant predicts worse Acute GVHD and survival but not relapse in a large retrospective cohort.
- Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor Cells, and oxidative stress.
- Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity.
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Su...
- Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery Disease.
- Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor Cell counts in patients with psoriasis: Etanercept, vascular function and endoth...
- Comparison of Outcomes of Allogeneic Transplantation for CML with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan or TBI.
- Successful treatment of severe immune hemolytic Anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature.
- Circulating progenitor Cells are reduced in HIV-positive, anti-retroviral naive patients.
- Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell Lymphoma.
- Improved Survival After Transplantation of More Donor Plasmacytoid Dendritic or Naïve T Cells From Unrelated-Donor Marrow Grafts: Results From BMTCTN 0201.
- Tacrolimus/sirolimus versus tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic hematopoietic Cell transplantation.
- Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem Cell transplantation.
- Risk associations between HLA-DPB1 T-Cell epitope matching and outcome of unrelated hematopoietic Cell transplantation are independent of HLA-DPA1.
- Similar Survival for Patients Undergoing Reduced-Intensity Total Body Irradiation (TBI) Versus Myeloablative TBI as Conditioning for Allogeneic Transplant in Acute Leu...
- High Incidence of Severe aGVHD with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplant Patients.
- Outcomes of hematopoietic cell transplantation for diffuse large B cell Lymphoma transformed from follicular Lymphoma.
- Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival.
- Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast Cancer.
- Reduced-intensity hematopoietic Cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow tran...
- Evaluation of peripheral blood stem Cell quality in products transported by traditional courier or commercial overnight shipping services.
- Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation...
- In vivo T cell costimulation blockade with abatacept for Acute graft-versus-host disease prevention: a first-in-disease trial.
- Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for Acute myeloid leukemia in first complete remission.
- Effect of Progenitor Cell Mobilization With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Peripheral Artery Disease: A Randomized Clinical Trial.
- Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic Cell transplants from partially mismatched unrelated donors.
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
- The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy.
- Temporal changes in plerixafor administration and hematopoietic stem Cell mobilization efficacy: results of a prospective clinical trial in multiple myeloma.
- Providing Personalized Prognostic Information for Adult Leukemia Survivors.
- Bortezomib-containing induction regimens in transplant-eligible Myeloma patients: A meta-analysis of phase 3 randomized clinical trials.
- Better Leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI.
- Autologous haematopoietic cell transplantation for non-Hodgkin Lymphoma with secondary CNS involvement.
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhi...
- Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma.
- Enrichment of IL-12-Producing Plasmacytoid Dendritic Cells in Donor Bone Marrow Grafts Enhances Graft-Versus-Leukemia Activity in Allogeneic Hematopoietic Stem Cell Tr...
- Unrelated donor allogeneic transplantation after failure of autologous transplantation for Acute myeloid leukemia: a study from the cibmtr.
- Finding the sweet spot for donor lymphocyte infusions.
- Mobilization of Hematopoietic Progenitors from Normal Donors Using the Combination of Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulati...
- Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III ...
- Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
- Soluble FAS ligand as a biomarker of disease recurrence in differentiated thyroid Cancer.
- Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell Lymphoma: a cohort analysis from the center for international blood and marrow ...
- Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant reci...
- Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.
- A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with Lymphoma.
- Tools to optimize the functionality of a Leukemia clinical trial team.
- Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and Etoposide results in predictable drug levels and durable long-term survival in Lymphoma ...
- Natural suppressor Cells; past, present and future.
- The regulation and activity of interleukin-12.
- IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus Leukemia activity.
- Recovery and rebound of platelet counts in mice after thrombocytopenia induced by combination bortezomib + romidepsin.
- Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity.
- Cryopreserved mesenchymal stromal Cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-? licensing.
- Treatment of severe neutropenia with high-dose pyridoxine in a patient with Chronic graft versus host disease and squamous cell carcinoma: a case report.
- Classifying Cytogenetics in Patients with AML in Complete Remission Undergoing Allogeneic Transplantation: A CIBMTR Study.
- Absence of vasoactive intestinal Peptide expression in hematopoietic Cells enhances Th1 polarization and antiviral immunity in mice.
- NK-Cell education after allogeneic transplantation: dissociation between recovery of cytokine producing and cytotoxic functions.
- Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after Acute ST-elevation myocardial infarction.
- One-Antigen Mismatched Related versus HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in Adults with Acute Leukemia: Center for International Blood...
- Effectiveness and cost analysis of "just-in-time" salvage plerixafor administration in autologous transplant patients with poor stem Cell mobilization kinetics.
- Impact of immune modulation with anti-T Cell antibodies on outcomes of reduced intensity allogeneic hematopoietic Cell transplantation for hematologic malignancies.
- Prevention of transfusion-transmitted cytomegalovirus in low-birth weight infants (≤1500 g) using cytomegalovirus-seronegative and leukoreduced t...
- A randomized clinical trial comparing granulocyte-colony-stimulating factor administration sites for mobilization of peripheral blood stem Cells for patients with hema...
- CD34(+) Cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.
- Receiver operating characteristic curve analysis of circulating blood dendritic Cell precursors and T Cells predicts response to extracorporeal photopheresis in patien...
- Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow Grafts versus bone marrow or peripheral blood Grafts from HLA-matched sibling donors for p...
- A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple Myeloma: a dose- and schedule-finding study.
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for Acute myeloid leukemia in first remission with unfavorable cytogeneti...
- Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with Acute myeloid leukemia in first complete remission or with mye...
- Activation, immune polarization, and graft-versus-Leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in...
- PKCtheta is required for alloreactivity and GVHD but not for immune responses toward Leukemia and infection in mice.
- Dichotomous role of interferon-gamma in allogeneic bone marrow transplant.
- Howell-Jolly body-like inclusions in neutrophils.
- Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with Peripheral arter...
- Neutropenia in a patient treated with ipilimumab (anti-CTLA-4 antibody).
- Howell-Jolly bodies in patients with Chronic GVHD.
- Donor dendritic Cells dance the do-si-do in allogeneic transplantation.
- Unrelated donor transplants in adults with Philadelphia-negative Acute lymphoblastic leukemia in first complete remission.
- Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection.
- Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor Cell transplantation.
- Reduced-intensity conditioning for unrelated donor progenitor Cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.
- Long-term outcome of Hodgkin Disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation--a similar experience.
- Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
- Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor Cells.
- CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
- The yin and yang of adaptive immunity in allogeneic hematopoietic Cell transplantation: donor antigen-presenting Cells can either augment or inhibit donor T Cell allor...
- Treatment of relapsed Acute leukemia after allogeneic transplantation: a single center experience.
- The role of sargramostim (rhGM-CSF) as immunotherapy.
- Expression of the plasmacytoid dendritic Cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
- Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
- Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor Cell transplantation for multiple myeloma.
- The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma Cells that is a...
- Vaccinia virus tropism for primary hematolymphoid Cells is determined by restricted expression of a unique virus receptor.
- Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without Graft-versus-host disease after allogeneic bone marrow transplantation.
- A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-s...
Schools
Joan Sanford I Weill Medical College Of Cornell University
Stanford University Med Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
Stanford University -
Weill Cornell Medical College of Cornell University
Hospital
-
Emory University Hospital -
Emory University Hospital Midtown -
Grady Memorial Hospital
Drug Facts
| NPI NUMBER | 1366550931 | |
| NPPES Provider LastName | WALLER | |
| NPPES Provider FirstName | EDMUND | |
| NPPES Provider ZIPCode | 303221013 | |
| NPPES Provider State | GA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 483.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 3.93 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366550931 |
| Last Name Of The Provider | WALLER |
| First Name Of The Provider | EDMUND |
| View All |
Similar Doctors
|
|
Dr. Richard C. Lauer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna J. Janss, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sujatha Murali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa C. Richardson, MD |
|
|
Teresa Robinson, CPNP |
|
Dr. Shawn M. Jobe, MD
This Doctor is OpenDoctor Recommended.
|